187 related articles for article (PubMed ID: 3027400)
1. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.
Martin S; Moss B; Berman PW; Laskey LA; Rouse BT
J Virol; 1987 Mar; 61(3):726-34. PubMed ID: 3027400
[TBL] [Abstract][Full Text] [Related]
2. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
Rosenthal KL; Smiley JR; South S; Johnson DC
J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
[TBL] [Abstract][Full Text] [Related]
3. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
Martin S; Rouse BT
J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
Zarling JM; Moran PA; Lasky LA; Moss B
J Virol; 1986 Aug; 59(2):506-9. PubMed ID: 3016312
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.
Martin S; Cantin E; Rouse BT
Ann N Y Acad Sci; 1988; 532():257-72. PubMed ID: 2845846
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus glycoprotein D is recognized as antigen by CD4+ and CD8+ T lymphocytes from infected mice. Characterization of T cell clones.
Johnson RM; Lancki DW; Fitch FW; Spear PG
J Immunol; 1990 Jul; 145(2):702-10. PubMed ID: 1973187
[TBL] [Abstract][Full Text] [Related]
7. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.
Martin S; Mercadal CM; Weir JP; Rouse BT
Viral Immunol; 1993; 6(1):21-33. PubMed ID: 8386515
[TBL] [Abstract][Full Text] [Related]
8. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
[TBL] [Abstract][Full Text] [Related]
9. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.
Witmer LA; Rosenthal KL; Graham FL; Friedman HM; Yee A; Johnson DC
J Gen Virol; 1990 Feb; 71 ( Pt 2)():387-96. PubMed ID: 2155292
[TBL] [Abstract][Full Text] [Related]
11. A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.
McLaughlin-Taylor E; Willey DE; Cantin EM; Eberle R; Moss B; Openshaw H
J Gen Virol; 1988 Jul; 69 ( Pt 7)():1731-4. PubMed ID: 2839606
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of herpes simplex virus (HSV) glycoprotein D in vaccinia recombinants affects their ability to protect from cutaneous HSV-2 disease.
Wachsman M; Aurelian L; Smith CC; Perkus ME; Paoletti E
J Infect Dis; 1989 Apr; 159(4):625-34. PubMed ID: 2538519
[TBL] [Abstract][Full Text] [Related]
13. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
14. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.
Hanke T; Graham FL; Rosenthal KL; Johnson DC
J Virol; 1991 Mar; 65(3):1177-86. PubMed ID: 1847447
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
16. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
Rooney JF; Wohlenberg C; Cremer KJ; Moss B; Notkins AL
J Virol; 1988 May; 62(5):1530-4. PubMed ID: 2833606
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
Martin S; Cantin E; Rouse BT
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
[TBL] [Abstract][Full Text] [Related]
18. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
19. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
Hendricks RL; Epstein RJ; Tumpey T
Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
[TBL] [Abstract][Full Text] [Related]
20. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
